Literature DB >> 1698280

A novel C-T transition within the distal CCAAT motif of the G gamma-globin gene in the Japanese HPFH: implication of factor binding in elevated fetal globin expression.

S Fucharoen1, K Shimizu, Y Fukumaki.   

Abstract

Hereditary persistence of fetal hemoglobin (HPFH) is a condition characterized by the continued expression of the fetal globin gene in adulthood. Both deletional and nondeletional forms have been described. We studied one Japanese family with two different nondeletional forms of HPFH. Analysis of polymorphic restriction sites in the beta-globin gene cluster suggested that one affecting both G gamma and A gamma globin expression in two members of the family could be associated with unknown conditions not linked to the beta-globin gene loci. Characterization by the polymerase chain reaction (PCR) of another form producing a G gamma-HPFH phenotype in two other members demonstrated a novel C-T transition at the nucleotide -114 within the distal CCAAT motif of the G gamma-globin gene. Using gel retardation assays on various nuclear extracts, we also demonstrated that this novel mutation abolishes the binding of the ubiquitous CCAAT binding factor, CP1 to the distal CCAAT motif of the gamma-globin gene but does not affect the binding of any erythroid specific factor, thereby suggesting a possible role for CP1 in the developmental regulation of fetal globin expression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698280      PMCID: PMC332148          DOI: 10.1093/nar/18.17.5245

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  51 in total

1.  Molecular heterogeneity of beta-thalassaemia in the Japanese: identification of two novel mutations.

Authors:  S Fucharoen; T Katsube; G Fucharoen; H Sawada; H Oishi; M Katsuno; J Nishimura; S Motomura; Y Miura; Y Fukumaki
Journal:  Br J Haematol       Date:  1990-01       Impact factor: 6.998

2.  Increased gamma-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor.

Authors:  D I Martin; S F Tsai; S H Orkin
Journal:  Nature       Date:  1989-03-30       Impact factor: 49.962

3.  Mutually exclusive interaction of the CCAAT-binding factor and of a displacement protein with overlapping sequences of a histone gene promoter.

Authors:  A Barberis; G Superti-Furga; M Busslinger
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

4.  G gamma beta+ hereditary persistence of fetal hemoglobin: cosmid cloning and identification of a specific mutation 5' to the G gamma gene.

Authors:  F S Collins; C J Stoeckert; G R Serjeant; B G Forget; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

5.  A history of the human fetal globin gene duplication.

Authors:  S H Shen; J L Slightom; O Smithies
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

6.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

7.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

8.  Globin chain electrophoresis: a new approach to the determination of the G gamma/A gamma ratio in fetal haemoglobin and to studies of globin synthesis.

Authors:  B P Alter; S C Goff; G D Efremov; M E Gravely; T H Huisman
Journal:  Br J Haematol       Date:  1980-04       Impact factor: 6.998

9.  A gene controlling fetal hemoglobin expression in adults is not linked to the non-alpha globin cluster.

Authors:  A M Gianni; M Bregni; M D Cappellini; G Fiorelli; R Taramelli; B Giglioni; P Comi; S Ottolenghi
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  A molecular study of a family with Greek hereditary persistence of fetal hemoglobin and beta-thalassemia.

Authors:  B Giglioni; C Casini; R Mantovani; S Merli; P Comi; S Ottolenghi; G Saglio; C Camaschella; U Mazza
Journal:  EMBO J       Date:  1984-11       Impact factor: 11.598

View more
  18 in total

Review 1.  Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease.

Authors:  Betty S Pace; Li Liu; Biaoru Li; Levi H Makala
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

2.  Functional profile of the human fetal gamma-globin gene upstream promoter region.

Authors:  H J Lin; C Y Han; A W Nienhuis
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

3.  Molecular mechanism of high hemoglobin F production in Southeast Asian-type hereditary persistence of fetal hemoglobin.

Authors:  Khaimuk Changsri; Varaporn Akkarapathumwong; Duangporn Jamsai; Pranee Winichagoon; Suthat Fucharoen
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

4.  Compound heterozygosity for a beta zero-thalassemia (frameshift codons 38/39; -C) and a nondeletional Swiss type of HPFH (A----C at NT -110, G gamma) in a Czechoslovakian family.

Authors:  K Indrak; J Indrakova; F Kutlar; D Pospisilova; I Sulovska; E Baysal; T H Huisman
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

5.  Compound loss of function of nuclear receptors Tr2 and Tr4 leads to induction of murine embryonic β-type globin genes.

Authors:  Shuaiying Cui; Osamu Tanabe; Michael Sierant; Lihong Shi; Andrew Campbell; Kim-Chew Lim; James Douglas Engel
Journal:  Blood       Date:  2015-01-05       Impact factor: 22.113

Review 6.  Fetal globin gene repressors as drug targets for molecular therapies to treat the β-globinopathies.

Authors:  Mikiko Suzuki; Masayuki Yamamoto; James Douglas Engel
Journal:  Mol Cell Biol       Date:  2014-07-14       Impact factor: 4.272

Review 7.  Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies.

Authors:  Vigneshwaran Venkatesan; Saranya Srinivasan; Prathibha Babu; Saravanabhavan Thangavel
Journal:  Mol Cell Biol       Date:  2020-12-21       Impact factor: 4.272

8.  Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β0-thalassemia/HbE disease.

Authors:  Pinyaphat Khamphikham; Orapan Sripichai; Thongperm Munkongdee; Suthat Fucharoen; Sissades Tongsima; Duncan R Smith
Journal:  Int J Hematol       Date:  2017-10-24       Impact factor: 2.490

9.  Regulation of embryonic/fetal globin genes by nuclear hormone receptors: a novel perspective on hemoglobin switching.

Authors:  A Filipe; Q Li; S Deveaux; I Godin; P H Roméo; G Stamatoyannopoulos; V Mignotte
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

10.  Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding.

Authors:  Gabriella E Martyn; Beeke Wienert; Lu Yang; Manan Shah; Laura J Norton; Jon Burdach; Ryo Kurita; Yukio Nakamura; Richard C M Pearson; Alister P W Funnell; Kate G R Quinlan; Merlin Crossley
Journal:  Nat Genet       Date:  2018-04-02       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.